Lemen RA. 2004a. Asbestos in brakes: exposure and risk of disease. Am J Ind Med 45(3):229–237. Lemen RA. 2004b. Chrysotile asbestos as a cause of mesothe- lioma: application of the Hill causation model. Int J Occup Environ Health 10:233–239. Li L, Sun TD, Zhang X, Lai RN, Li SY, Fan XJ, et al. 2004. Cohort studies on cancer mortality among workers exposed only to chrysotile asbestos: a meta-analysis. Biomed Environ Sci 17(4):459–468. Lin RT, Takahashi K, Karjalainen A, Wilson D, Kameda T, Chan CC, et al. 2007. Ecological association between asbestos-related diseases and historical asbestos consumption: an inter- national analysis. Lancet 20(9564):844–849. Loomis D, Dement J, Richardson D, Wolf S. 2009. Lung can- cer mortality and fibre exposures among North Carolina asbestos textile workers. Occup Environ Med 66:535–542. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. 2004. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to pres- ence of SV40 sequences in common laboratory plasmids. Lancet 364(9440):1157–1166. McCulloch J. 2006. Saving the asbestos industry, 1960 to 2006. Public Health Rep 121:609–614. McCulloch J, Tweedale G. 2008. Defending the Indefensible: The Global Asbestos Industry and Its Fight for Survival. Oxford, UK:Oxford University Press. Michaels D. 2006. Manufactured uncertainty: protecting pub- lic health in the age of contested science and product defense. Ann NY Acad Sci 1076:149–162. Michaels D. 2008. Doubt Is Their Product. How Industry’s Assault on Science Threatens Your Health. New York:Oxford University Press. Michaels D. 2009. Addressing conflict in strategic literature reviews: disclosure is not enough. J Epidemiol Community Health 63(8):599–600. Michaels D, Monforton C. 2007. How litigation shapes the sci- entific literature: asbestos and disease among automobile mechanics. J Law Policy 5(3):1137–1169. Mirabelli D, Calisti R, Barone-Adesi F, Fornero E, Merletti F, Magnani C. 2008. Excess of mesotheliomas alter expo- sure to chrysotile in Balangero, Italy. Occup Environ Med 65(12):815–819. National Cancer Institute. 2003. Asbestos Exposure and Cancer. Bethesda, MD:National Institutes of Health. Available: http://www.cancer.gov/cancertopics/factsheet/Risk/ asbestos [accessed 27 April 2010]. NIOSH (National Institute for Occupational Safety and Health). 2010. Draft NIOSH Current Intelligence Bulletin. Asbestos and Other Elongate Mineral Particles: State of the Science and Roadmap for Research, Version 4. Available: http://www.cdc.gov/niosh/review/public/099-C/pdfs/ AsbestosRoadmapPublicCommentDraftV4.pdf [accessed 1 May 2010]. NTP (National Toxicology Program). 1980. Asbestos: CAS No. 1332-21-4. In: First Report on Carcinogens. Research Triangle Park, NC:National Toxicology Program, 21–53. NTP. 2004. 11th Report on Carcinogens, Research Triangle Park, NC:National Toxicology Program. Available: http://ntp. niehs.nih.gov/ntp/roc/toc11.html [accessed 27 May 2009]. Natural Resources Canada. 2006. Chrysotile. Available: http://www.nrcan.gc.ca/mms-smm/busi-indu/cmy-amc/ content/2006/20.pdf [accessed 2 May 2010]. Occupational Safety and Health Administration. 1994. Occupational exposure to asbestos: final rule. Fed Reg 59:40964–41162. Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. 2005. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 172(8):1019–1025. Pasetto R, Comba P, Marconi A. 2005. Mesothelioma associated with environmental exposures. Med Lav 96(4):330–337. Perrin Conferences. 2010. A Conference on Asbestos and Mesothelioma, 3–4 May 2010, Encore at Wynn Las Vegas, Las Vegas, NV. Available: https://www.perrinconferences. com/html/previous_events-asbestos_meso_conf.html [accessed 17 May 2010]. Price MJ, Darnton AJ, McElvenny DM, Hodgson JT. 2007. Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond) 58(8):564–568. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. 2009. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 100(7):1175–1183. Rotterdam Convention. 2005. On the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade. Available: http://www.unido. org/fileadmin/user_media/Services/Environmental_ Management/GUDDIS/Legal_Frameworks/rotterdam_ convention.pdf [accessed 28 April 2010]. Roushdy-Hammady I, Siegal J, Emri S, Testa JR, Carbone M. 2001. Genetic-susceptibility factor and malignant meso- thelioma in the Cappadocian region of Turkey. Lancet 357:444–445. Rushton L, Hutchings S, Brown T. 2008. The burden of cancer at work: estimation as the first step to prevention. Occup Environ Med 65(12):787–788. Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley- Phillips JK, Everitt JI, Tewksbury EW, et al. 2009. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 4(11):708–710. Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. 2009. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbes- tos? Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(5):511–529. Saracci R, Simonato L. 2001. Familial malignant mesothelioma. Lancet 358:1813–1814. Silverstein MA, Welch LS, Lemen R. 2009. Developments in asbestos cancer risk assessment. Am J Ind Med 15:850–858. Smith AH, Wright CC. 1996. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med 30:252–266. Stayner LT, Dankovic DA, Lemen RA. 1996. Occupational expo- sure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health 86:179–186. Stayner L, Smith R, Bailer J, Gilbert S, Steenland K, Dement J, et al. 1997. Exposure-response analysis of risk of respira- tory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med 54:646–652. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. 2009. A review of human carcinogens— part C: metals, arsenic, dusts, and fibres. Lancet Oncol 10(5):453–454. Takaro TK, Davis D, Van Rensburg SJ, Aguilar RSA, Algranti E, Bailar JC III, et al. 2010. Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing world [Letter]. Int J Occup Environ Health 16(2):241–248. Terracini B. 2007. The role of asbestos fiber dimension in the prevention of mesothelioma. Int J Occup Environ Health 13:64–69. Tomatis L, Cantoni S, Carnevale F, Merler E, Mollo F, Ricci P, et al. The case for a global ban on asbestos 2007. The role of asbestos fiber dimension in the prevention of mesothelioma. Int J Occup Environ Health 13:64–69. Tossavainen A. 1997. Asbestos, asbestosis and cancer: the Helsinki criteria for diagnosis and attribution. Consensus report. Scand J Work Environ Health 23:311–316. Tossavainen A. 2000. International expert meeting on new advances in the radiology and screening of asbestos- related diseases. Consensus report. Scand J Work Environ Health 26:449–454. Tossavainen A. 2004. Global use of asbestos and incidence of mesothelioma. Int J Occup Environ Health 10:22–25. United Nations Environment Program 1998. Chrysotile Asbestos. Environmental Health Criteria 203. Geneva:World Health Organization. Available: http://www.inchem.org/documents/ ehc/ehc/ehc203.htm [accessed 18 May 2010]. United Nations Statistics Division. 2009. United Nations Statistics Division Homepage. Available: http://unstats. un.org/unsd/default.htm [accessed 3 March 2010]. U.S. EPA. (U.S. Environmental Protection Agency). 1986. Airborne Asbestos Health Assessment Update. EPA/6000/8- 84/003E. Washington, DC:U.S. EPA. USGS. 2009. Asbestos. In: 2008 Minerals Yearbook [Advance Release]. Reston,VA:U.S. Geological Survey, 8.1-8.6. Available: http://minerals.usgs.gov/minerals/pubs/ commodity/asbestos/myb1-2008-asbes.pdf [accessed 7 June 2010]. Vinikoor LC, Larson TC, Bateson TF, Birnbaum L. 2010. Exposure to Asbestos-Containing Vermiculite Ore and Respiratory Symptoms among Individuals Who Were Children While the Mine Was Active in Libby, Montana. Environ Health Perspect 118:1033–1038; doi:10.1289/ehp.0901680 [Online 23 March 2010]. Virta RL. 2005. Mineral Commodity Profiles—Asbestos. U.S. Geological Survey Circular 1255-KK. Available: http://pubs. usgs.gov/circ/2005/1255/kk/ [accessed 3 May 2010]. Welch LS. 2007. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health 13:318–327. Welch L, Anderson HA, Balmes J, Braun L, Brody A, Castleman B, et al. 2009. Research on mesothelioma from brake exposure: corporate influence remains relevant concern. Int J Occup Environ Health 15(2):234–238. WHO (World Health Organization). 2005. WHO Workshop on Mechanisms of Fibre Carcinogenesis and Assessment of Chrysotile Asbestos Substitutes, November 8–12, 2005, Lyon, France. Available: http://www.who.int/ipcs/publications/ new_issues/summary_report.pdf [accessed 29 April 2010]. WHO (World Health Organization). 2006. Elimination o f A s b e s t o s - R e l a t e d D i s e a s e s . G e n e v a : W H O . Available: http://www.who.int/occupational_health/ publications/asbestosrelateddisease/en/index.html [accessed 27 April 2010]. WHO (World Health Organization). 2007. WHO Calls for Prevention of Cancer through Healthy Workplaces. Geneva:WHO. Available: http://www.who.int/mediacentre/ news/notes/2007/np19/en/index.html [accessed 29 April 2010]. World Bank Group. 2009. Good Practice Note: Asbestos: Occupational and Community Health Issues. Available: http://siteresources.worldbank.org/EXTPOPS/Resources/ AsbestosGuidanceNoteFinal.pdf [accessed 3 March 2010]. World Trade Organization. 2001. European Communities— Measures Affecting Asbestos and Asbestos-Containing Products. WT/DS135/R. Available: http://www.ali.org/doc/ wto/wto2001/Asbestos.pdf [accessed 27 April 2010]. Environmental Health Perspectives • volume 118 | number 7 | July 2010 901